Stay updated on Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page.

Latest updates to the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a minor update to the study record documentation.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRevision tag updated to v3.6.4, indicating the current build of the page. It replaces the previous v3.6.3.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a small patch or update to the page template or internal documentation. This appears to be an incremental improvement rather than a substantive content modification.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page's underlying software version was updated from v3.6.0 to v3.6.2, indicating a patch-level release.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page now shows recruitment has ended and adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) to aid user navigation. It also reflects a minor header formatting change to Intervention/Treatment and updates the revision tag from v3.5.5 to v3.6.0.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing Revision: v3.5.4, indicating an updated version of the page content. It is a metadata update and does not modify the study details.SummaryDifference0.0%

Stay in the know with updates to Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page.